product

rebound

Baudax Bio Inc

crash

$BXRX This is like a bloody car crash - I cannot look away.

flow

Money flow now &quot;extreme bearish.&quot;

management

BXRX management and BOD are the definition of FAILURE!!

$BXRX Watching all the new bulls here compared to a month ago, some of you will end up bag holding this for a long time.. this company has some of the most selfish management in the entire market.

This can only be due to fraudulent practices on the part of Baudax Bio management, such as misrepresenting the market potential of Anjeso, lying about the CEO&#39;s credentials, colluding with short sellers, etc.

i’ve watched it for years.. nothing good ever happens with management

Stay far, far away from this toxic stock, company and management.

but that this  company is allowed to continue to serve as an ATM for management, while fleecing investors, is an absolute travesty.

BXRX management should be in jail for what they did to this company.

Company has no viable products, no revenue, incompetent, self-dealing management, multiple dilutions and reverse splits.

split

Look at all the reverse splits in this turd.

$BXRX fucking turds, two splits in one year, Good lord.

$BXRX  😂😂 and yet another split on the way,  what a horrific stock.

A 1 for 40 reverse stock split and an immediate dilution/stock offering……..in other words………a savage ass pounding without even a cigarette break.

stop

but this thang don’t stop tumbling down the mountain

$BXRX Even if they don&#39;t sell Anjeso, the product is unique in a market with great potential.

$EMED QB ticker announced  new product , .01-.03 nice % incoming i believe

$BXRX THE COMPANY HAS AN EXCELLENT PRODUCT MILOXICAM IV FOR PAIN RELIEF.

A unique product on the market that will soon be marketed internationally as well.

Everything that got a haircut today, probably sees a nice rebound tomorrow.

news

$ENSC big news coming in days ahead,  very cheap.

Mid day top percent stock gainers on news and/or vol.

$INPX $BIAF $GROM $BXRX $COSM  very strong holding  above 1.90 that great news for tomorrow

We are the only low float good news stock today.

Analysts have set a price target of $3 for ENSC&#39;s stock, making it a strong buy for those looking to invest in the future of the industry🔥🚀 
 
Also following: 
$THMO $HUBC $TRKA $BXRX

$REVB More and More buys from all over the market are entering here now.

$INPX volume swelling on buys coming in locking it up
$BXRX go bulls!

🚨   $SPRC This could be the greatest buy in small caps right now or at least one of them.

Prty more up, cosm $4 buy spot,  Htgm filling premarket, slapping in 🔥

hold

$BXRX Long term hold for me PT 10 🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀

.It will move on thin air 
$sidu is a nice hold 
$boxd nice volume.

$BXRX Once again bulls prove they can&#39;t hold shit

$BXRX as long as it holds the VWAP it is still bullish.

Anavex Life Sciences Corporation

wait

Seems crazy to me to unjust approvals that are going on while we wait on legitimate results!!!

But why wait 3 years with that when Anavex 50mg dose is likely better! !

So, if one waits months for an answer and then has to resubmit to another journal it can hold things up.

This is a shitshow till data is presented.

loss

but  losses  and  disappointment  with  Missling.

$AVXL Took my $250 loss and Got out guys too much noise not enough action.

but was faked by the move and held them to expiration and had to book a loss of $19,000.

shareholder

The krout has proven to be an a hole toward shareholders.

Missling is a greedy pig, doesnt see the bad he does by delaying intentionally, not only to shareholders,

i am telling for years that we need to fire that shitty guy just here to full his pockets without any consideration for his shareholders.

.this guy doesnt respect his shareholders and he must be sue for that.

$AVXL fire Missling, he has been here 9 years and done nothing to drive shareholder value other than BS hype

$AVXL why does the company not believe they are beholden to their shareholders?

$AVXL Unfortunately the Investorshub AVXL board has deteriorated to the point that it is basically a board consisting of almost entirely FUD with almost more bashers than true shareholders.

Messling is grossly deficient in anticipating the expectations of shareholders and the market.

$AVXL as corporate shareholder, I have sent an email on dec. 21st and a friendly reminder yesterday to IR - no response yet !!

One hand he says he care for shareholder value, on other hand he is purposely not sharing updates.

shareprice

$AVXL missling next time should change a few letters when hiring and SP will improve: from FDA to FBI former employee.

$AVXL Every time Missling speaks, the SP tanks…..amateurish communication, unbelievable.

It&#39;s stupid, it wastes time (and $$$) and it leaves the company vulnerable with a supressed SP.

Based on Rett alone, SP is well under 100$, sorry to bust your ballown,but please try to stay realist and keep a little credibility!

$AVXL The sp is wrong there must be a glitch

$AVXL not that i am happy with the SP overall

$AVXL Until you realize that and admit that the presenter screwed up in rushing the presentation the SP will stay where it’s at

$AVXL wandering when we will cross ANVS SP ;) 
never again!!!!

$AVXL we didnt cross ANVS SP yet, no good haha!

show

Take your money from this shit show and deposit in your bank account.

What an absolute unregulated criminal shit show this market has become.

Missling shows poor judgement and is not suited to be ceo.

SHOWS THE EXTREME WEAKNESS AND  DISTRESS THE STOCK IS UNDER.

but need more time to evaluate and announce a conference call for Monday instead we have a shit show.

They have a great product treating cancer with immunotherapy, peer reviewed journal

look into Adamis Pharma, no more speculation, now it&#39;s real, two FDA approved meds, two major products, top of the line in comparison of their rivals, for cheaper price, AND WITH NO MUCH COMPETITION!

2023  is  going  to  be  very  positive  for  patients  of  our  products  and  shareholders  alike

Their product works (see the mad Pole Piotr’s graphs 😵‍💫)
Multi year holds, the bodadem.

We have great data out of a superior product,

They have good products and a solid future.

but I feel a rebound a big big rebound it’s just something telling me but man I feel it

business-result

Anavex&#39;s A2-73 Blarcamesine&#39;s trial results on 2 previously completed adult phase-3 trials were highly successful.

But the company actually has never seen before wonderful results.

If results hold up, the stock will achieve massive gains.

The results were excellent on the 2 completed adult trials, and because the 3rd trial is pediatric and early on the disease, they are expected to perform even better.

Alzheimer&#39;s is the most valuable and most difficult indication and most desired lately..  and only Anavex really has some great results with a great safety record. .

The  sava  results  trounce  you  guys  🤦🏻‍♂️🤦🏻‍♂️🤦🏻‍♂️😂😂😂

Sava has potential and the phase 3 results will show the truth.

drug

- Timo grimmer is in the team 
- All endpoints of the clinical trial were reached 
 
I firmly believe that the drug works and that the CEO has done a good job no matter how much he is criticized.

we have a drug, even many drugs, good for so many indications,  to become a giant pharma, we are about to get billions in revenues.

$AVXL The improvements in the drug arm cannot be lucky. .

I&#39;m looking forward to seeing the long term AD data on ANVS and have the feeling it&#39;s going to end up being the best in class AD treatment as well.

Do not listen to any FUD this drug is the real deal.

$AVXL amazing to see the actual benefits to people and their families of this “miracle drug” as they call it

$AVXL Dr. Perry said we have a legendary drug which actually reverses AD and is safe unlike Adulhelm.

trial

$AVXL amazing  avxl  still  in  singke  digits  after  a  supposedly  amazing  “pivotal”  trial  readout  🤦🏻‍♂️🤦🏻‍♂️🤦🏻‍♂️😂😂😂

$AVXL The trial met both co-primary and secondary endpoints showing statistically significant reduction of clinical decline as measured by those endpoints.

$AVXL Australia trial data meets the gold standard.

2-73 has orphan designation for Rett which combined with the multiple Rett trials and it very good safety record should make it a great candidate for AA.

This company has yet to fail to meet endpoints on any trial and the thousands of papers on the MOA  eliminates fraud with science, and the company is in great fiscal shape so no shenanigans there.

Bluebird bio Inc

company

$BLUE seriously, how can a company be so bad at execution?

.i hate this fuccccccing company 🖕🏼🖕🏼🖕🏼

Plenty of other companies are mentioned and while we can pick one or two sentences out of the lengthy form that might make you get excited i just do not believe theres anything there indicating a BO or even a partnership.

It’s agonizing as we have not heard a feedback or response from the company regarding it. 1.

$BLUE The overall Market and the delay (NO COMMUNICATION) from the company leads to a substantial decrease in stock value.

Seems like company management hates its own shareholders

$BLUE this company is so defenseless, they don&#39;t even delete the vulgar replies to their tweets.

hand

didnt know there were so many weak hands.

Cash on hand going DOWN daily with no progress toward commercialization.

They use many tactics to scare the money right out of your hands.

but the cash burn compared with cash on hand is concerning.

It means they are worried and with do whatever is necessary to scare weak hands.

Losses creating more losses to recoup other losses lol

$BLUE   Well, lol, beginning with ZERO DOLLARS , this statement is not ROCKET  SCIENCE, lol, yet, yet , earnings will still show a LOSS against revenues !!!

The idea of selling this at a $3,000 loss after sitting on it since July is unacceptable.

Now I am  sitting just about at a loss hope there isn’t much more downside.

$BLUE the stop losses getting triggered today must be frustrating.

$PRVB reported losses and missed revenue target. BOOM.

move

Everything else moves and we just sit in the same spot.

$BLUE   Well well well…..up 300 on the DOW and this pos , is that, a turd.

This pos was $6.50 after they got their first drug approved , lol…Aug 2022..and you are still here at $6.50 !!!!

And so, you have it…a lousy ending to this pos

This pos burnt so many from $100, they changed mgmt and it still hasn’t fixed the problem.

Here to make money, this pos doesn’t deserve to be even listed.

Now, disregarding product revenue, there is enough cash for the company to enter 2024 with confidence.

Even if the rebound doesn&#39;t start today as long as we stay above 6 I think we are set up for a solid run this week.

but good news, I am sending Andrew a gift! https://bagofdicks.com/

The silence will break soon with really good news

$BLUE tuff market   But good news around the corner.

$BLUE The most positive news is it’s one day closer to the earnings release and one day closer to the BLA submission plus this is currently a rare day where this is beating out the XBI and LABU by not being down as much.

$BLUE very bullish here and ready for news any moment or day

I would expect some very good news and a turn around to come very soon. 🤞

This is trading like good news is coming! !

potential

Way to maximize the talent pool and help everyone reach their potential BLUE!!

Watching these for potentially more upside continuation next week.

Large potential population of users
6. good/honest management
7.

Sign up today and start receiving expert insights on potential market opportunities 
 
📈FREE trade-of-week via(Google Search) ⟶  𝐟𝐫𝐞𝐞𝐚𝐥𝐞𝐫𝐭.𝐩𝐰

though because there is just  so much potential for BLUE now.

entry

Good entry on friday..ill wait for a 10% profit..amd out, untul next leg.. 🤑🤑🤑

$BLUE almost $4, may be is s good entry point soon.

Attractive entry for the long term potential here.

$BLUE well if there was ever a good entry point it was there today in my opinion

We provide all ENTRIES and EXITS clearly!

We provide all of our ENTRIES and EXITS for the plays, give you the plan and guide you along those plans.

BXRX

Baudax Bio Inc

-52.79%

$3.41 - $1.61

Nov, 29, 2022

Nov, 5, 2022

AVXL

Anavex Life Sciences Corporation

-22.55%

$11.75 - $9.10

Jan, 13, 2023

Jan, 6, 2023

Divihomes is Now Live

BLUE

Bluebird bio Inc

-31.24%

$6.69 - $4.60

Jan, 18, 2023

Oct, 24, 2022

BXRX

Baudax Bio Inc

-52.79%

$3.41 - $1.61

Nov, 29, 2022

Nov, 5, 2022

Oct, 11, 2022

Oct, 7, 2022

AVXL

Anavex Life Sciences Corporation

-22.55%

$11.75 - $9.10

Jan, 13, 2023

Jan, 6, 2023

Dec, 14, 2022

Dec, 6, 2022

Dec, 5, 2022

Oct, 18, 2022

BLUE

Bluebird bio Inc

-31.24%

$6.69 - $4.60

Jan, 18, 2023

Oct, 24, 2022